{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:45:43Z","timestamp":1792089943003,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11154-3","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:42:39Z","timestamp":1789022559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study"],"prefix":"10.1007","volume":"34","author":[{"given":"Michael","family":"Frass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lechleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Gr\u00fcndling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Duscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Muchitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto C.","family":"Burghuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"11154_CR1","unstructured":"American Cancer Society: Facts and Figures. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/global-cancer-facts-and-figures\/global-cancer-facts-and-figures-2024.pdf accessed August 9, 2025, 08.49 pm"},{"issue":"5","key":"11154_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jtho.2022.03.002","volume":"17","author":"C Poleri","year":"2022","unstructured":"Poleri C (2022) Sex-based differences in lung cancer: does it matter? J Thorac Oncol 17(5):599\u2013601. https:\/\/doi.org\/10.1016\/j.jtho.2022.03.002","journal-title":"J Thorac Oncol"},{"key":"11154_CR3","unstructured":"American Cancer Society: Lung cancer. https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html accessed August 9, 2025, 08.52 am"},{"issue":"1","key":"11154_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LEL Hendriks","year":"2024","unstructured":"Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM, Tan DSW, Veronesi G, Reck M (2024) Non-small-cell lung cancer. Nat Rev Dis Primers 10(1):71. https:\/\/doi.org\/10.1038\/s41572-024-00551-9","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"11154_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s0885-3924(02)00376-7","volume":"23","author":"K Tanaka","year":"2002","unstructured":"Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y (2002) Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 23(5):417\u2013423. https:\/\/doi.org\/10.1016\/s0885-3924(02)00376-7","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"11154_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cllc.2017.02.008","volume":"18","author":"EJ Morrison","year":"2017","unstructured":"Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM (2017) Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer 18(5):497\u2013503. https:\/\/doi.org\/10.1016\/j.cllc.2017.02.008","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"11154_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/cncr.11578","volume":"98","author":"D Cella","year":"2003","unstructured":"Cella D, Peterman A, Hudgens S, Webster K, Socinski MA (2003) Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). Cancer 98(4):822\u2013831. https:\/\/doi.org\/10.1002\/cncr.11578","journal-title":"Cancer"},{"issue":"1","key":"11154_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cncr.24703","volume":"116","author":"XS Wang","year":"2010","unstructured":"Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS (2010) Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer 116(1):137\u2013145. https:\/\/doi.org\/10.1002\/cncr.24703","journal-title":"Cancer"},{"issue":"13","key":"11154_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1200\/jco.2010.33.4631","volume":"30","author":"JA Sloan","year":"2012","unstructured":"Sloan JA, Zhao X, Novotny PJ, Wampfler J, Garces Y, Clark MM, Yang P (2012) Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol 30(13):1498\u20131504. https:\/\/doi.org\/10.1200\/jco.2010.33.4631","journal-title":"J Clin Oncol"},{"issue":"4","key":"11154_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/pon.1091","volume":"16","author":"BJ Daly","year":"2007","unstructured":"Daly BJ, Douglas SL, Foley H, Lipson A, Liou CF, Bowman K, Kwilosz D, Koroukian S, O\u2019Toole E, Smyth K, Townsend A, VonGruenigen V, Rose J (2007) Psychosocial registry for persons with cancer: a method of facilitating quality of life and symptom research. Psychooncology 16(4):358\u2013364. https:\/\/doi.org\/10.1002\/pon.1091","journal-title":"Psychooncology"},{"issue":"8","key":"11154_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41568-024-00708-4","volume":"24","author":"A Boire","year":"2024","unstructured":"Boire A, Burke K, Cox TR, Guise T, Jamal-Hanjani M, Janowitz T, Kaplan R, Lee R, Swanton C, Vander Heiden MG, Sahai E (2024) Why do patients with cancer die? Nat Rev Cancer 24(8):578\u2013589. https:\/\/doi.org\/10.1038\/s41568-024-00708-4","journal-title":"Nat Rev Cancer"},{"key":"11154_CR12","first-page":"92","volume-title":"Lectures on Homoeopathic Philosophy","author":"J Kent","year":"1993","unstructured":"Kent J (1993) Lectures on Homoeopathic Philosophy. B. Jain Publishers Ltd, New Delhi, India, pp 92\u20133"},{"key":"11154_CR13","volume-title":"Organon of Medicine","author":"S Hahnemann","year":"2002","unstructured":"Hahnemann S (2002) Organon of Medicine, 5th & 6th Edition. B Jain Publishers Pvt Ltd, Noida, Uttar Pradesh","edition":"5th & 6th Editi"},{"issue":"3","key":"11154_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ctim.2015.03.004","volume":"23","author":"M Frass","year":"2015","unstructured":"Frass M, Friehs H, Thallinger C, Sohal NK, Marosi C, Muchitsch I, Gaertner K, Gleiss A, Schuster E, Oberbaum M (2015) Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - a pragmatic randomized controlled trial. Complement Ther Med 23(3):309\u2013317. https:\/\/doi.org\/10.1016\/j.ctim.2015.03.004","journal-title":"Complement Ther Med"},{"key":"11154_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ctim.2016.06.001","volume":"27","author":"A Gleiss","year":"2016","unstructured":"Gleiss A, Frass M, Gaertner K (2016) Re-analysis of survival data of cancer patients utilizing additive homeopathy. Complement Ther Med 27:65\u201367. https:\/\/doi.org\/10.1016\/j.ctim.2016.06.001","journal-title":"Complement Ther Med"},{"issue":"12","key":"11154_CR16","doi-asserted-by":"publisher","first-page":"e1930","DOI":"10.1002\/onco.13548(retracted;seereference17)","volume":"25","author":"M Frass","year":"2020","unstructured":"Frass M, Lechleitner P, Gr\u00fcndling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmair M, Gaertner K, Duscheck C, Muchitsch I, Marosi C, Schumacher M, Z\u00f6chbauer-M\u00fcller S, Manchanda RK, Schrott A, Burghuber O (2020) Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study. Oncologist 25(12):e1930\u2013e1955. https:\/\/doi.org\/10.1002\/onco.13548(retracted;seereference17)","journal-title":"Oncologist"},{"key":"11154_CR17","doi-asserted-by":"publisher","unstructured":"Retraction of: Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study (2025) Oncologist 30(11):oyaf364. https:\/\/doi.org\/10.1093\/oncolo\/oyaf364","DOI":"10.1093\/oncolo\/oyaf364"},{"issue":"6","key":"11154_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/rheumatology\/keq234","volume":"50","author":"S Brien","year":"2011","unstructured":"Brien S, Lachance L, Prescott P, McDermott C, Lewith G (2011) Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford) 50(6):1070\u20131082. https:\/\/doi.org\/10.1093\/rheumatology\/keq234","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 4","key":"11154_CR19","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/s0959-8049(01)00448-8","volume":"38","author":"P Fayers","year":"2002","unstructured":"Fayers P, Bottomley A (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(Suppl 4):S125\u2013S133. https:\/\/doi.org\/10.1016\/s0959-8049(01)00448-8","journal-title":"Eur J Cancer"},{"issue":"3","key":"11154_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-item health survey 1.0. Health Econ 2(3):217\u201327. https:\/\/doi.org\/10.1002\/hec.4730020305","journal-title":"Health Econ"},{"issue":"14","key":"11154_CR21","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1200\/JCO.22.02544","volume":"41","author":"GV Scagliotti","year":"2023","unstructured":"Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D (2023) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 41(14):2458\u20132466. https:\/\/doi.org\/10.1200\/JCO.22.02544","journal-title":"J Clin Oncol"},{"key":"11154_CR22","unstructured":"Muchitsch I (2015) Remedy production and quality, potentisation. In: Frass MMB (ed) Homeopathy in intensive and emergency medicine. Narayana Publishers, Kandern, Germany, pp 37\u201355"},{"issue":"4","key":"11154_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/1534735406295041","volume":"5","author":"MJ Verhoef","year":"2006","unstructured":"Verhoef MJ, Vanderheyden LC, F\u00f8nneb\u00f8 V (2006) A whole systems research approach to cancer care: why do we need it and how do we get started? Integr Cancer Ther 5(4):287\u2013292. https:\/\/doi.org\/10.1177\/1534735406295041","journal-title":"Integr Cancer Ther"},{"issue":"12","key":"11154_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1089\/jicm.2022.0753","volume":"29","author":"B Kligler","year":"2023","unstructured":"Kligler B, Khung M, Schult T, Whitehead A (2023) What we have learned about the implementation of whole health in the Veterans Administration. J Integr Complement Med 29(12):774\u2013780. https:\/\/doi.org\/10.1089\/jicm.2022.0753","journal-title":"J Integr Complement Med"},{"issue":"3","key":"11154_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/10755530260127961","volume":"8","author":"MJ Verhoef","year":"2002","unstructured":"Verhoef MJ, Casebeer AL, Hilsden RJ (2002) Assessing efficacy of complementary medicine: adding qualitative research methods to the \u201cgold standard.\u201d J Altern Complement Med 8(3):275\u2013281. https:\/\/doi.org\/10.1089\/10755530260127961","journal-title":"J Altern Complement Med"},{"issue":"4","key":"11154_CR26","first-page":"32","volume":"9","author":"C Ritenbaugh","year":"2003","unstructured":"Ritenbaugh C, Verhoef M, Fleishman S, Boon H, Leis A (2003) Whole systems research: a discipline for studying complementary and alternative medicine. Altern Ther Health Med 9(4):32\u201336","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"11154_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctim.2005.05.001","volume":"13","author":"MJ Verhoef","year":"2005","unstructured":"Verhoef MJ, Lewith G, Ritenbaugh C, Boon H, Fleishman S, Leis A (2005) Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med 13(3):206\u2013212. https:\/\/doi.org\/10.1016\/j.ctim.2005.05.001","journal-title":"Complement Ther Med"},{"issue":"9674","key":"11154_CR28","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(09)60569-9","volume":"373","author":"R Pirker","year":"2009","unstructured":"Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O\u2019Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U, FLEX Study Team (2009) Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373(9674):1525\u20131531. https:\/\/doi.org\/10.1016\/S0140-6736(09)60569-9","journal-title":"Lancet"},{"issue":"3","key":"11154_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O'Brien","year":"1979","unstructured":"O\u2019Brien PC, Fleming TR (1979) A multiple testing procedure for clinical trials. Biometrics 35(3):549\u2013556. https:\/\/doi.org\/10.2307\/2530245","journal-title":"Biometrics"},{"issue":"2","key":"11154_CR30","first-page":"36","volume":"13","author":"B Derrick","year":"2018","unstructured":"Derrick B, Ruck A, Toher D, White P (2018) \u201cTests for equality of variances between two samples which contain both paired observations and independent observations\u201d (PDF). J Appl Quantitative Methods 13(2):36\u201347","journal-title":"J Appl Quantitative Methods"},{"key":"11154_CR31","unstructured":"Maxwell, Scott E.; Delaney, Harold D. (2004). Designing experiments and analyzing data: a model comparison. Lawrence Erlbaum Associates. pp. 217\u2013218. ISBN 0\u20138058\u20133718\u20133."},{"key":"11154_CR32","unstructured":"https:\/\/www.meduniwien.ac.at\/web\/mitarbeiterinnen\/it-hilfe-support\/it4science\/plattformen\/rda\/ accessed July 5, 2026, 9.44 pm"},{"key":"11154_CR33","unstructured":"https:\/\/data-science.meduniwien.ac.at\/en\/institutes\/medical-statistics\/ accessed July 5, 2026, 9.48 pm"},{"key":"11154_CR34","unstructured":"https:\/\/www.meduniwien.ac.at\/web\/en\/about-us\/organisation\/committees\/data-clearing-house\/ accessed July 5, 2026, 9.52 pm"},{"issue":"1","key":"11154_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144. https:\/\/doi.org\/10.1200\/JCO.1998.16.1.139","journal-title":"J Clin Oncol"},{"key":"11154_CR36","doi-asserted-by":"publisher","unstructured":"Cocks K, King MT, Velikova G, de Castro G Jr, Martyn St-James M, Fayers PM, Brown JM (2012) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 48(11):1713\u201321. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.059","DOI":"10.1016\/j.ejca.2012.02.059"},{"issue":"8","key":"11154_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733\u2013742. https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"N Engl J Med"},{"key":"11154_CR38","doi-asserted-by":"publisher","DOI":"10.1200\/OA-25-00154","volume":"3","author":"B Daly","year":"2026","unstructured":"Daly B, Bryl KL, Santos Teles M, Baser RE, Mao JJ (2026) Survival results from the Integrative Medicine for Patient-Reported Outcomes, Values, and Experience (IMPROVE) trial. JCO Oncol Adv 3:e2500154. https:\/\/doi.org\/10.1200\/OA-25-00154","journal-title":"JCO Oncol Adv"},{"issue":"1","key":"11154_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02313-2","volume":"12","author":"HJ Hamre","year":"2023","unstructured":"Hamre HJ, Glockmann A, von Ammon K, Riley DS, Kiene H (2023) Efficacy of homoeopathic treatment: systematic review of meta-analyses of randomised placebo-controlled homoeopathy trials for any indication. Syst Rev 12(1):191. https:\/\/doi.org\/10.1186\/s13643-023-02313-2","journal-title":"Syst Rev"},{"key":"11154_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/957506","author":"C Eyles","year":"2011","unstructured":"Eyles C, Leydon GM, Lewith GT, Brien S (2011) A grounded theory study of homeopathic practitioners\u2019 perceptions and experiences of the homeopathic consultation. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2011\/957506","journal-title":"Evid Based Complement Alternat Med"},{"key":"11154_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1472-6882-6-37","volume":"6","author":"TD Thompson","year":"2006","unstructured":"Thompson TD, Weiss M (2006) Homeopathy - what are the active ingredients? An exploratory study using the UK Medical Research Council\u2019s framework for the evaluation of complex interventions. BMC Complement Altern Med 6:37. https:\/\/doi.org\/10.1186\/1472-6882-6-37","journal-title":"BMC Complement Altern Med"},{"issue":"7651","key":"11154_CR42","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bmj.39524.439618.25","volume":"336","author":"TJ Kaptchuk","year":"2008","unstructured":"Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336(7651):999\u20131003. https:\/\/doi.org\/10.1136\/bmj.39524.439618.25","journal-title":"BMJ"},{"key":"11154_CR43","doi-asserted-by":"publisher","first-page":"205031212110009","DOI":"10.1177\/20503121211000918","volume":"9","author":"M Akdeniz","year":"2021","unstructured":"Akdeniz M, Yard\u0131mc\u0131 B, Kavukcu E (2021) Ethical considerations at the end-of-life care. SAGE Open Med 9:20503121211000920. https:\/\/doi.org\/10.1177\/20503121211000918","journal-title":"SAGE Open Med"},{"issue":"4","key":"11154_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100225","volume":"6","author":"GB Crawford","year":"2021","unstructured":"Crawford GB, Dzier\u017canowski T, Hauser K, Larkin P, Luque-Blanco AI, Murphy I, Puchalski CM, Ripamonti CI (2021) Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines. ESMO Open 6(4):100225. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100225","journal-title":"ESMO Open"},{"key":"11154_CR45","first-page":"76","volume":"2","author":"R L\u00fcdtke","year":"2008","unstructured":"L\u00fcdtke R, Musial F (2008) Wie kann man komplement\u00e4rmedizinische Verfahren in ihrer Wirksamkeit erforschen? Komplement\u00e4rmedizinische Methoden 2:76\u201381","journal-title":"Komplement\u00e4rmedizinische Methoden"},{"key":"11154_CR46","doi-asserted-by":"publisher","DOI":"10.1055\/a-2797-3848","author":"JF de Carvalho","year":"2026","unstructured":"de Carvalho JF (2026) Antidotes in homeopathy: classical doctrine, clinical relevance and scientific re-interpretation. Homeopathy. https:\/\/doi.org\/10.1055\/a-2797-3848","journal-title":"Homeopathy"},{"issue":"22","key":"11154_CR47","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378(22):2078\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1801005","journal-title":"N Engl J Med"},{"issue":"7023","key":"11154_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"DL Sackett","year":"1996","unstructured":"Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn\u2019t. BMJ 312(7023):71\u201372. https:\/\/doi.org\/10.1136\/bmj.312.7023.71","journal-title":"BMJ"},{"issue":"1","key":"11154_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JOP.18.00554","volume":"15","author":"S Latte-Naor","year":"2019","unstructured":"Latte-Naor S, Mao JJ (2019) Putting integrative oncology into practice: concepts and approaches. J Oncol Pract 15(1):7\u201314. https:\/\/doi.org\/10.1200\/JOP.18.00554","journal-title":"J Oncol Pract"},{"key":"11154_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgx012","author":"CM Witt","year":"2017","unstructured":"Witt CM, Balneaves LG, Cardoso MJ, Greenlee H, Johnstone P, K\u00fcc\u00fck \u00d6, Mailman J, Mao JJ (2017) A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgx012","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"11154_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/acm.2012.0533","volume":"20","author":"M Frenkel","year":"2014","unstructured":"Frenkel M, Cohen L (2014) Effective communication about the use of complementary and integrative medicine in cancer care. J Altern Complement Med 20(1):12\u201318. https:\/\/doi.org\/10.1089\/acm.2012.0533","journal-title":"J Altern Complement Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11154-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:43Z","timestamp":1792086463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11154-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11154"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11154-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We provide a full and explicit disclosure of all professional activities of the investigators related to the HMPs used in this study. No financial incentives, commercial interests, reimbursements, marketing activities or performance-related benefits were associated with patient recruitment, participation, or study outcomes. The conduct of the study and the reporting of results were independent of any financial considerations linked to the HMPs. There was no connection between the conduct of the study and private practice.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We did not use AI or AI-assisted technologies in the writing process.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Add-on homeopathic care could be delivered alongside conventional oncological treatment without observed interference or adverse effects.In this trial, quality of life was better in NSCLC patients allocated to add-on homeopathy than in those allocated to placebo.Survival was longer in the homeopathy group; this observation requires independent replication.","order":3,"name":"Ethics","label":"Key messages\/lessons learned","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"952"}}